HighTower Advisors
AXDX

HighTower Advisors’s Accelerate Diagnostics AXDX Stock Holding History

HighTower Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,374
Closed -$31K – 3452
2023
Q1 		$31K Hold
4,374
– – ﹤0.01% 3101
2022
Q4 		$31K Buy
4,374
+800
+22% +$8.73K ﹤0.01% 3087
2022
Q3 		$54K Hold
3,574
– – ﹤0.01% 2868
2022
Q2 		$36K Sell
3,574
-156
-4% -$1.38K ﹤0.01% 2945
2022
Q1 		$53K Buy
3,730
+2,000
+116% +$57K ﹤0.01% 3065
2021
Q4 		$91K Buy
1,730
+40
+2% +$2.23K ﹤0.01% 2941
2021
Q3 		$98K Sell
1,690
-1,021
-38% -$66.6K ﹤0.01% 2849
2021
Q2 		$217K Buy
+2,711
New +$216K ﹤0.01% 2606
2020
Q1 		– Sell
-1,081
Closed -$183K – 2232
2019
Q4 		$183K Buy
+1,081
New +$178K ﹤0.01% 1996
2019
Q3 		– Sell
-1,269
Closed -$289K – 2417
2019
Q2 		$289K Buy
1,269
+282
+29% +$55.1K ﹤0.01% 1822
2019
Q1 		$207K Buy
+987
New +$185K ﹤0.01% 1940
2018
Q4 		– Sell
-1,048
Closed -$240K – 2211
2018
Q3 		$240K Buy
1,048
+61
+6% +$13.5K ﹤0.01% 1843
2018
Q2 		$220K Sell
987
-69
-7% -$15.4K ﹤0.01% 1849
2018
Q1 		$241K Buy
1,056
+120
+13% +$31.5K ﹤0.01% 1784
2017
Q4 		$246K Buy
+936
New +$219K ﹤0.01% 1803
2017
Q3 		– Sell
-823
Closed -$226K – 2232
2017
Q2 		$226K Sell
823
-800
-49% -$217K ﹤0.01% 1784
2017
Q1 		$393K Sell
1,623
-55
-3% -$12.6K ﹤0.01% 1435
2016
Q4 		$348K Buy
1,678
+447
+36% +$106K ﹤0.01% 1405
2016
Q3 		$334K Sell
1,231
-75
-6% -$16.6K ﹤0.01% 1402
2016
Q2 		$188K Buy
+1,306
New +$175K ﹤0.01% 1507
2015
Q4 		– Sell
-1,070
Closed -$174K – 2048
2015
Q3 		$174K Buy
+1,070
New +$232K ﹤0.01% 1666
2014
Q1 		– Sell
-1,631
Closed -$199K – 1602
2013
Q4 		$199K Buy
1,631
+524
+47% +$70K ﹤0.01% 1313
2013
Q3 		$173K Buy
+1,107
New +$98.8K ﹤0.01% 1177

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HighTower Advisors's AXDX Position: Q2 2023 in Review

HighTower Advisors sold out of Accelerate Diagnostics (AXDX) in Q2 2023, closing a stake of 4,374 shares — an estimated $31K sold.

HighTower Advisors first reported a position in AXDX in Q3 2013 and held it in 23 quarters. The position peaked at $393K in Q1 2017. 51 funds tracked by Wall St. Rank hold AXDX as of Q2 2023.

  • HighTower Advisors reported no remaining Accelerate Diagnostics position as of Q2 2023 after selling out during the quarter.
  • HighTower Advisors sold 4,374 Accelerate Diagnostics shares in Q2 2023, an estimated $31K.
  • HighTower Advisors first reported a position in Accelerate Diagnostics in Q3 2013 and held it in 23 quarters.
  • HighTower Advisors's Accelerate Diagnostics position peaked at $393K in Q1 2017.
  • 51 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2023.

Based on HighTower Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.